To study the effect of CD38 expression on other laboratory parameters, we found that all CD38-positive mature B-cell lymphoma patients had significant thrombocytopenia compared to CD38-negative patients. The gene discussed is CD38; the disease is B-cell non-Hodgkin lymphoma.